Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
Diagnosis and Management of Neuropathic Pain
BMJ 339:391-395, Freynhagen,R. &Bennett,M.I., 2009
Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guideline
BMJ 388:e079970, Busse,J.W.,et al, 2025
Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage
Stroke 52:1390-1397, Micieli, A.,et al, 2021
Early Risk of Readmission Following Hospitalization for Reversible Cerebral Vasoconstriction Syndrome
Neurol 96:e2912-e2919, Garg, A.,et al, 2021
Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage
Stroke 50:529-536, Bower, M.M.,et al, 2019
Andexxa-An Antidote for Apixaban and Rivaroxaban
JAMA 320:399-400, , 2018
Acute Viral Encephalitis
NEJM 379:357-366, Tyler,K.L., 2018
Continuous and Routine EEG in Intensive Care
Neurol 81:2002-2008, Ney, J.P.,et al, 2013
Headache rate and cost of care following lumbar puncture at a single tertiary care hospital
Neurol 77:71-74, Dakka, Y.,et al, 2011
Generic Antiepileptic Drugs and Associated Medical Resource Utilization in the United States
Neurol 74:1566-1574, 1562, Labiner,D.M., et al, 2010
Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010
The Risks and Costs of Multiple-Generic Substitution of Topiramate
Neurol 72:2122-2129, Duh,M.S.,et al, 2009
The Value of Specifying Brand-Name Antiepileptic Drugs
Arch Neurol 66:1415-1416, 1418, Ng,Y., 2009
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Arch Neurol 66:1417-1418, Hamiwka,L., 2009
Repetitive Strain Injury
Lancet 369:1815-1822, van Tulder,M.,et al, 2007
Surgery versus Prolonged Conservative Treatment for Sciatica
NEJM 356:2245-2256,2239, Peul,W.C.,et al, 2007